nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—CYP3A4—Pimecrolimus—atopic dermatitis	0.0998	0.122	CbGbCtD
Ergonovine—ABCB1—Tacrolimus—atopic dermatitis	0.0991	0.121	CbGbCtD
Ergonovine—ABCB1—Loratadine—atopic dermatitis	0.0725	0.0888	CbGbCtD
Ergonovine—ABCB1—Methylprednisolone—atopic dermatitis	0.0663	0.0813	CbGbCtD
Ergonovine—CYP3A4—Tacrolimus—atopic dermatitis	0.0594	0.0727	CbGbCtD
Ergonovine—CYP3A4—Loratadine—atopic dermatitis	0.0435	0.0532	CbGbCtD
Ergonovine—ABCB1—Betamethasone—atopic dermatitis	0.0431	0.0528	CbGbCtD
Ergonovine—ABCB1—Prednisolone—atopic dermatitis	0.0426	0.0521	CbGbCtD
Ergonovine—ABCB1—Hydrocortisone—atopic dermatitis	0.0403	0.0494	CbGbCtD
Ergonovine—ABCB1—Prednisone—atopic dermatitis	0.0402	0.0492	CbGbCtD
Ergonovine—CYP3A4—Methylprednisolone—atopic dermatitis	0.0397	0.0487	CbGbCtD
Ergonovine—CYP3A4—Triamcinolone—atopic dermatitis	0.0301	0.0369	CbGbCtD
Ergonovine—CYP3A4—Betamethasone—atopic dermatitis	0.0258	0.0317	CbGbCtD
Ergonovine—CYP3A4—Prednisolone—atopic dermatitis	0.0255	0.0312	CbGbCtD
Ergonovine—ABCB1—Dexamethasone—atopic dermatitis	0.0251	0.0307	CbGbCtD
Ergonovine—CYP3A4—Hydrocortisone—atopic dermatitis	0.0242	0.0296	CbGbCtD
Ergonovine—CYP3A4—Prednisone—atopic dermatitis	0.0241	0.0295	CbGbCtD
Ergonovine—CYP3A4—Dexamethasone—atopic dermatitis	0.015	0.0184	CbGbCtD
Ergonovine—Myasthenia gravis—Betamethasone—atopic dermatitis	0.00428	0.0239	CcSEcCtD
Ergonovine—Myasthenia gravis—Dexamethasone—atopic dermatitis	0.00428	0.0239	CcSEcCtD
Ergonovine—Nasal congestion—Fluocinonide—atopic dermatitis	0.00363	0.0203	CcSEcCtD
Ergonovine—Drug interaction—Loratadine—atopic dermatitis	0.00341	0.019	CcSEcCtD
Ergonovine—Nasal congestion—Dimenhydrinate—atopic dermatitis	0.00328	0.0183	CcSEcCtD
Ergonovine—Nasal congestion—Diphenhydramine—atopic dermatitis	0.00328	0.0183	CcSEcCtD
Ergonovine—Nasal congestion—Pimecrolimus—atopic dermatitis	0.00317	0.0177	CcSEcCtD
Ergonovine—Sweating—Desonide—atopic dermatitis	0.00302	0.0168	CcSEcCtD
Ergonovine—Ventricular arrhythmia—Tacrolimus—atopic dermatitis	0.00292	0.0163	CcSEcCtD
Ergonovine—Nasal congestion—Mometasone—atopic dermatitis	0.00217	0.0121	CcSEcCtD
Ergonovine—Cramps of lower extremities—Tacrolimus—atopic dermatitis	0.00199	0.0111	CcSEcCtD
Ergonovine—Hyperhidrosis—Desonide—atopic dermatitis	0.00194	0.0108	CcSEcCtD
Ergonovine—Pulmonary oedema—Tacrolimus—atopic dermatitis	0.00193	0.0107	CcSEcCtD
Ergonovine—Tinnitus—Dimenhydrinate—atopic dermatitis	0.00193	0.0107	CcSEcCtD
Ergonovine—Tinnitus—Diphenhydramine—atopic dermatitis	0.00193	0.0107	CcSEcCtD
Ergonovine—Thrombophlebitis—Tacrolimus—atopic dermatitis	0.00181	0.0101	CcSEcCtD
Ergonovine—Nasal congestion—Tacrolimus—atopic dermatitis	0.00172	0.00961	CcSEcCtD
Ergonovine—Vertigo—Dimenhydrinate—atopic dermatitis	0.00161	0.009	CcSEcCtD
Ergonovine—Vertigo—Diphenhydramine—atopic dermatitis	0.00161	0.009	CcSEcCtD
Ergonovine—Palpitations—Dimenhydrinate—atopic dermatitis	0.00159	0.00885	CcSEcCtD
Ergonovine—Palpitations—Diphenhydramine—atopic dermatitis	0.00159	0.00885	CcSEcCtD
Ergonovine—Tinnitus—Loratadine—atopic dermatitis	0.00148	0.00827	CcSEcCtD
Ergonovine—Hyperhidrosis—Diphenhydramine—atopic dermatitis	0.00142	0.00791	CcSEcCtD
Ergonovine—Hyperhidrosis—Dimenhydrinate—atopic dermatitis	0.00142	0.00791	CcSEcCtD
Ergonovine—Hypotension—Diphenhydramine—atopic dermatitis	0.00137	0.00764	CcSEcCtD
Ergonovine—Hypotension—Dimenhydrinate—atopic dermatitis	0.00137	0.00764	CcSEcCtD
Ergonovine—Dyspnoea—Pimecrolimus—atopic dermatitis	0.00126	0.00705	CcSEcCtD
Ergonovine—Headache—Desonide—atopic dermatitis	0.00126	0.00701	CcSEcCtD
Ergonovine—Pulmonary oedema—Prednisolone—atopic dermatitis	0.00123	0.00686	CcSEcCtD
Ergonovine—Palpitations—Loratadine—atopic dermatitis	0.00122	0.00682	CcSEcCtD
Ergonovine—Pulmonary oedema—Hydrocortisone—atopic dermatitis	0.0012	0.0067	CcSEcCtD
Ergonovine—Hypertension—Loratadine—atopic dermatitis	0.0012	0.00666	CcSEcCtD
Ergonovine—Acute coronary syndrome—Tacrolimus—atopic dermatitis	0.00119	0.00665	CcSEcCtD
Ergonovine—Myocardial infarction—Tacrolimus—atopic dermatitis	0.00119	0.00661	CcSEcCtD
Ergonovine—Chest pain—Loratadine—atopic dermatitis	0.00118	0.00657	CcSEcCtD
Ergonovine—Sweating—Tacrolimus—atopic dermatitis	0.00116	0.00647	CcSEcCtD
Ergonovine—Gastrointestinal pain—Pimecrolimus—atopic dermatitis	0.00116	0.00647	CcSEcCtD
Ergonovine—Thrombophlebitis—Prednisolone—atopic dermatitis	0.00116	0.00646	CcSEcCtD
Ergonovine—Haematuria—Tacrolimus—atopic dermatitis	0.00115	0.00643	CcSEcCtD
Ergonovine—Thrombophlebitis—Hydrocortisone—atopic dermatitis	0.00113	0.00631	CcSEcCtD
Ergonovine—Pulmonary oedema—Triamcinolone—atopic dermatitis	0.00113	0.0063	CcSEcCtD
Ergonovine—Pulmonary oedema—Methylprednisolone—atopic dermatitis	0.00113	0.00629	CcSEcCtD
Ergonovine—Abdominal pain—Pimecrolimus—atopic dermatitis	0.00112	0.00625	CcSEcCtD
Ergonovine—Vertigo—Fluocinolone Acetonide—atopic dermatitis	0.00112	0.00623	CcSEcCtD
Ergonovine—Shock—Loratadine—atopic dermatitis	0.00111	0.0062	CcSEcCtD
Ergonovine—Bradycardia—Tacrolimus—atopic dermatitis	0.00111	0.00616	CcSEcCtD
Ergonovine—Hallucination—Tacrolimus—atopic dermatitis	0.00108	0.00602	CcSEcCtD
Ergonovine—Dizziness—Fluocinonide—atopic dermatitis	0.00108	0.006	CcSEcCtD
Ergonovine—Thrombophlebitis—Triamcinolone—atopic dermatitis	0.00107	0.00594	CcSEcCtD
Ergonovine—Thrombophlebitis—Methylprednisolone—atopic dermatitis	0.00106	0.00593	CcSEcCtD
Ergonovine—Hypotension—Loratadine—atopic dermatitis	0.00106	0.00589	CcSEcCtD
Ergonovine—Pulmonary oedema—Betamethasone—atopic dermatitis	0.00103	0.00572	CcSEcCtD
Ergonovine—Pulmonary oedema—Dexamethasone—atopic dermatitis	0.00103	0.00572	CcSEcCtD
Ergonovine—Headache—Fluocinonide—atopic dermatitis	0.00102	0.00568	CcSEcCtD
Ergonovine—Tinnitus—Tacrolimus—atopic dermatitis	0.00101	0.00565	CcSEcCtD
Ergonovine—Chest pain—Mometasone—atopic dermatitis	0.00101	0.00564	CcSEcCtD
Ergonovine—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.001	0.0056	CcSEcCtD
Ergonovine—Diarrhoea—Diphenhydramine—atopic dermatitis	0.001	0.0056	CcSEcCtD
Ergonovine—Diarrhoea—Pimecrolimus—atopic dermatitis	0.00097	0.00541	CcSEcCtD
Ergonovine—Dizziness—Dimenhydrinate—atopic dermatitis	0.00097	0.00541	CcSEcCtD
Ergonovine—Dizziness—Diphenhydramine—atopic dermatitis	0.00097	0.00541	CcSEcCtD
Ergonovine—Thrombophlebitis—Betamethasone—atopic dermatitis	0.000967	0.00539	CcSEcCtD
Ergonovine—Thrombophlebitis—Dexamethasone—atopic dermatitis	0.000967	0.00539	CcSEcCtD
Ergonovine—Vomiting—Dimenhydrinate—atopic dermatitis	0.000933	0.0052	CcSEcCtD
Ergonovine—Vomiting—Diphenhydramine—atopic dermatitis	0.000933	0.0052	CcSEcCtD
Ergonovine—Gastrointestinal pain—Loratadine—atopic dermatitis	0.000924	0.00515	CcSEcCtD
Ergonovine—Headache—Dimenhydrinate—atopic dermatitis	0.000919	0.00512	CcSEcCtD
Ergonovine—Headache—Diphenhydramine—atopic dermatitis	0.000919	0.00512	CcSEcCtD
Ergonovine—Muscle spasms—Tacrolimus—atopic dermatitis	0.000909	0.00507	CcSEcCtD
Ergonovine—Vomiting—Pimecrolimus—atopic dermatitis	0.000902	0.00503	CcSEcCtD
Ergonovine—Pulmonary oedema—Prednisone—atopic dermatitis	0.000894	0.00498	CcSEcCtD
Ergonovine—Abdominal pain—Loratadine—atopic dermatitis	0.000893	0.00498	CcSEcCtD
Ergonovine—Headache—Pimecrolimus—atopic dermatitis	0.000889	0.00495	CcSEcCtD
Ergonovine—Nausea—Dimenhydrinate—atopic dermatitis	0.000871	0.00486	CcSEcCtD
Ergonovine—Nausea—Diphenhydramine—atopic dermatitis	0.000871	0.00486	CcSEcCtD
Ergonovine—Dyspnoea—Mometasone—atopic dermatitis	0.000864	0.00482	CcSEcCtD
Ergonovine—Vertigo—Tacrolimus—atopic dermatitis	0.000849	0.00474	CcSEcCtD
Ergonovine—Nausea—Pimecrolimus—atopic dermatitis	0.000842	0.0047	CcSEcCtD
Ergonovine—Thrombophlebitis—Prednisone—atopic dermatitis	0.000842	0.00469	CcSEcCtD
Ergonovine—Palpitations—Tacrolimus—atopic dermatitis	0.000836	0.00466	CcSEcCtD
Ergonovine—Hypertension—Tacrolimus—atopic dermatitis	0.000816	0.00455	CcSEcCtD
Ergonovine—Chest pain—Tacrolimus—atopic dermatitis	0.000805	0.00449	CcSEcCtD
Ergonovine—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000793	0.00442	CcSEcCtD
Ergonovine—Diarrhoea—Loratadine—atopic dermatitis	0.000773	0.00431	CcSEcCtD
Ergonovine—Abdominal pain—Mometasone—atopic dermatitis	0.000766	0.00427	CcSEcCtD
Ergonovine—Acute coronary syndrome—Prednisolone—atopic dermatitis	0.000762	0.00425	CcSEcCtD
Ergonovine—Shock—Tacrolimus—atopic dermatitis	0.000759	0.00423	CcSEcCtD
Ergonovine—Myocardial infarction—Prednisolone—atopic dermatitis	0.000758	0.00422	CcSEcCtD
Ergonovine—Dizziness—Loratadine—atopic dermatitis	0.000747	0.00416	CcSEcCtD
Ergonovine—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.000746	0.00416	CcSEcCtD
Ergonovine—Acute coronary syndrome—Hydrocortisone—atopic dermatitis	0.000744	0.00415	CcSEcCtD
Ergonovine—Myocardial infarction—Hydrocortisone—atopic dermatitis	0.00074	0.00412	CcSEcCtD
Ergonovine—Hypotension—Tacrolimus—atopic dermatitis	0.000721	0.00402	CcSEcCtD
Ergonovine—Vomiting—Loratadine—atopic dermatitis	0.000718	0.004	CcSEcCtD
Ergonovine—Headache—Loratadine—atopic dermatitis	0.000708	0.00395	CcSEcCtD
Ergonovine—Bradycardia—Prednisolone—atopic dermatitis	0.000706	0.00394	CcSEcCtD
Ergonovine—Acute coronary syndrome—Triamcinolone—atopic dermatitis	0.000701	0.00391	CcSEcCtD
Ergonovine—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	0.000699	0.0039	CcSEcCtD
Ergonovine—Myocardial infarction—Triamcinolone—atopic dermatitis	0.000697	0.00388	CcSEcCtD
Ergonovine—Myocardial infarction—Methylprednisolone—atopic dermatitis	0.000695	0.00388	CcSEcCtD
Ergonovine—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000695	0.00387	CcSEcCtD
Ergonovine—Bradycardia—Hydrocortisone—atopic dermatitis	0.00069	0.00385	CcSEcCtD
Ergonovine—Dyspnoea—Tacrolimus—atopic dermatitis	0.000688	0.00384	CcSEcCtD
Ergonovine—Sweating—Methylprednisolone—atopic dermatitis	0.00068	0.00379	CcSEcCtD
Ergonovine—Hallucination—Hydrocortisone—atopic dermatitis	0.000674	0.00376	CcSEcCtD
Ergonovine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000671	0.00374	CcSEcCtD
Ergonovine—Nausea—Loratadine—atopic dermatitis	0.000671	0.00374	CcSEcCtD
Ergonovine—Diarrhoea—Mometasone—atopic dermatitis	0.000663	0.0037	CcSEcCtD
Ergonovine—Bradycardia—Triamcinolone—atopic dermatitis	0.000649	0.00362	CcSEcCtD
Ergonovine—Bradycardia—Methylprednisolone—atopic dermatitis	0.000648	0.00361	CcSEcCtD
Ergonovine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000646	0.0036	CcSEcCtD
Ergonovine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000636	0.00355	CcSEcCtD
Ergonovine—Acute coronary syndrome—Betamethasone—atopic dermatitis	0.000636	0.00354	CcSEcCtD
Ergonovine—Acute coronary syndrome—Dexamethasone—atopic dermatitis	0.000636	0.00354	CcSEcCtD
Ergonovine—Hallucination—Methylprednisolone—atopic dermatitis	0.000633	0.00353	CcSEcCtD
Ergonovine—Myocardial infarction—Dexamethasone—atopic dermatitis	0.000632	0.00352	CcSEcCtD
Ergonovine—Myocardial infarction—Betamethasone—atopic dermatitis	0.000632	0.00352	CcSEcCtD
Ergonovine—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000631	0.00352	CcSEcCtD
Ergonovine—Vomiting—Mometasone—atopic dermatitis	0.000616	0.00344	CcSEcCtD
Ergonovine—Abdominal pain—Tacrolimus—atopic dermatitis	0.00061	0.0034	CcSEcCtD
Ergonovine—Headache—Mometasone—atopic dermatitis	0.000607	0.00339	CcSEcCtD
Ergonovine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000603	0.00336	CcSEcCtD
Ergonovine—Bradycardia—Dexamethasone—atopic dermatitis	0.000589	0.00329	CcSEcCtD
Ergonovine—Bradycardia—Betamethasone—atopic dermatitis	0.000589	0.00329	CcSEcCtD
Ergonovine—Hallucination—Dexamethasone—atopic dermatitis	0.000576	0.00321	CcSEcCtD
Ergonovine—Hallucination—Betamethasone—atopic dermatitis	0.000576	0.00321	CcSEcCtD
Ergonovine—Nausea—Mometasone—atopic dermatitis	0.000576	0.00321	CcSEcCtD
Ergonovine—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000554	0.00309	CcSEcCtD
Ergonovine—Myocardial infarction—Prednisone—atopic dermatitis	0.00055	0.00307	CcSEcCtD
Ergonovine—Vertigo—Prednisolone—atopic dermatitis	0.000543	0.00302	CcSEcCtD
Ergonovine—Vertigo—Hydrocortisone—atopic dermatitis	0.00053	0.00295	CcSEcCtD
Ergonovine—Diarrhoea—Tacrolimus—atopic dermatitis	0.000528	0.00294	CcSEcCtD
Ergonovine—Hypertension—Prednisolone—atopic dermatitis	0.000521	0.00291	CcSEcCtD
Ergonovine—Bradycardia—Prednisone—atopic dermatitis	0.000513	0.00286	CcSEcCtD
Ergonovine—Dizziness—Tacrolimus—atopic dermatitis	0.00051	0.00284	CcSEcCtD
Ergonovine—Hypertension—Hydrocortisone—atopic dermatitis	0.000509	0.00284	CcSEcCtD
Ergonovine—Hallucination—Prednisone—atopic dermatitis	0.000502	0.0028	CcSEcCtD
Ergonovine—Vertigo—Triamcinolone—atopic dermatitis	0.000499	0.00278	CcSEcCtD
Ergonovine—Vertigo—Methylprednisolone—atopic dermatitis	0.000498	0.00278	CcSEcCtD
Ergonovine—Vomiting—Tacrolimus—atopic dermatitis	0.000491	0.00274	CcSEcCtD
Ergonovine—Shock—Prednisolone—atopic dermatitis	0.000485	0.0027	CcSEcCtD
Ergonovine—Headache—Tacrolimus—atopic dermatitis	0.000483	0.00269	CcSEcCtD
Ergonovine—Hypertension—Triamcinolone—atopic dermatitis	0.000479	0.00267	CcSEcCtD
Ergonovine—Hypertension—Methylprednisolone—atopic dermatitis	0.000478	0.00267	CcSEcCtD
Ergonovine—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000476	0.00266	CcSEcCtD
Ergonovine—Shock—Hydrocortisone—atopic dermatitis	0.000474	0.00264	CcSEcCtD
Ergonovine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000465	0.00259	CcSEcCtD
Ergonovine—Nausea—Tacrolimus—atopic dermatitis	0.000458	0.00256	CcSEcCtD
Ergonovine—Vertigo—Betamethasone—atopic dermatitis	0.000453	0.00252	CcSEcCtD
Ergonovine—Vertigo—Dexamethasone—atopic dermatitis	0.000453	0.00252	CcSEcCtD
Ergonovine—Hypotension—Hydrocortisone—atopic dermatitis	0.00045	0.00251	CcSEcCtD
Ergonovine—Shock—Triamcinolone—atopic dermatitis	0.000446	0.00249	CcSEcCtD
Ergonovine—Shock—Methylprednisolone—atopic dermatitis	0.000445	0.00248	CcSEcCtD
Ergonovine—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000438	0.00244	CcSEcCtD
Ergonovine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000437	0.00244	CcSEcCtD
Ergonovine—Hypertension—Dexamethasone—atopic dermatitis	0.000435	0.00243	CcSEcCtD
Ergonovine—Hypertension—Betamethasone—atopic dermatitis	0.000435	0.00243	CcSEcCtD
Ergonovine—Hypotension—Methylprednisolone—atopic dermatitis	0.000423	0.00236	CcSEcCtD
Ergonovine—Shock—Dexamethasone—atopic dermatitis	0.000405	0.00226	CcSEcCtD
Ergonovine—Shock—Betamethasone—atopic dermatitis	0.000405	0.00226	CcSEcCtD
Ergonovine—Dyspnoea—Triamcinolone—atopic dermatitis	0.000404	0.00225	CcSEcCtD
Ergonovine—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000398	0.00222	CcSEcCtD
Ergonovine—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000398	0.00222	CcSEcCtD
Ergonovine—Vertigo—Prednisone—atopic dermatitis	0.000394	0.0022	CcSEcCtD
Ergonovine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000394	0.00219	CcSEcCtD
Ergonovine—Hypotension—Dexamethasone—atopic dermatitis	0.000384	0.00214	CcSEcCtD
Ergonovine—Hypotension—Betamethasone—atopic dermatitis	0.000384	0.00214	CcSEcCtD
Ergonovine—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000381	0.00212	CcSEcCtD
Ergonovine—Hypertension—Prednisone—atopic dermatitis	0.000379	0.00211	CcSEcCtD
Ergonovine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.00037	0.00206	CcSEcCtD
Ergonovine—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000358	0.00199	CcSEcCtD
Ergonovine—Shock—Prednisone—atopic dermatitis	0.000352	0.00196	CcSEcCtD
Ergonovine—Hyperhidrosis—Prednisone—atopic dermatitis	0.000346	0.00193	CcSEcCtD
Ergonovine—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000336	0.00187	CcSEcCtD
Ergonovine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000336	0.00187	CcSEcCtD
Ergonovine—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000329	0.00184	CcSEcCtD
Ergonovine—Dizziness—Prednisolone—atopic dermatitis	0.000326	0.00182	CcSEcCtD
Ergonovine—Abdominal pain—Betamethasone—atopic dermatitis	0.000325	0.00181	CcSEcCtD
Ergonovine—Abdominal pain—Dexamethasone—atopic dermatitis	0.000325	0.00181	CcSEcCtD
Ergonovine—Dizziness—Hydrocortisone—atopic dermatitis	0.000318	0.00177	CcSEcCtD
Ergonovine—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000309	0.00173	CcSEcCtD
Ergonovine—Headache—Prednisolone—atopic dermatitis	0.000309	0.00172	CcSEcCtD
Ergonovine—Vomiting—Hydrocortisone—atopic dermatitis	0.000306	0.00171	CcSEcCtD
Ergonovine—Headache—Hydrocortisone—atopic dermatitis	0.000302	0.00168	CcSEcCtD
Ergonovine—Dizziness—Triamcinolone—atopic dermatitis	0.0003	0.00167	CcSEcCtD
Ergonovine—Dizziness—Methylprednisolone—atopic dermatitis	0.000299	0.00167	CcSEcCtD
Ergonovine—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000293	0.00163	CcSEcCtD
Ergonovine—Nausea—Prednisolone—atopic dermatitis	0.000293	0.00163	CcSEcCtD
Ergonovine—Vomiting—Triamcinolone—atopic dermatitis	0.000288	0.00161	CcSEcCtD
Ergonovine—Vomiting—Methylprednisolone—atopic dermatitis	0.000288	0.0016	CcSEcCtD
Ergonovine—Nausea—Hydrocortisone—atopic dermatitis	0.000286	0.00159	CcSEcCtD
Ergonovine—Headache—Triamcinolone—atopic dermatitis	0.000284	0.00158	CcSEcCtD
Ergonovine—Headache—Methylprednisolone—atopic dermatitis	0.000283	0.00158	CcSEcCtD
Ergonovine—Abdominal pain—Prednisone—atopic dermatitis	0.000283	0.00158	CcSEcCtD
Ergonovine—Diarrhoea—Dexamethasone—atopic dermatitis	0.000281	0.00157	CcSEcCtD
Ergonovine—Diarrhoea—Betamethasone—atopic dermatitis	0.000281	0.00157	CcSEcCtD
Ergonovine—Dizziness—Dexamethasone—atopic dermatitis	0.000272	0.00152	CcSEcCtD
Ergonovine—Dizziness—Betamethasone—atopic dermatitis	0.000272	0.00152	CcSEcCtD
Ergonovine—Nausea—Triamcinolone—atopic dermatitis	0.000269	0.0015	CcSEcCtD
Ergonovine—Nausea—Methylprednisolone—atopic dermatitis	0.000269	0.0015	CcSEcCtD
Ergonovine—Vomiting—Dexamethasone—atopic dermatitis	0.000261	0.00146	CcSEcCtD
Ergonovine—Vomiting—Betamethasone—atopic dermatitis	0.000261	0.00146	CcSEcCtD
Ergonovine—Headache—Dexamethasone—atopic dermatitis	0.000258	0.00144	CcSEcCtD
Ergonovine—Headache—Betamethasone—atopic dermatitis	0.000258	0.00144	CcSEcCtD
Ergonovine—Diarrhoea—Prednisone—atopic dermatitis	0.000245	0.00137	CcSEcCtD
Ergonovine—Nausea—Betamethasone—atopic dermatitis	0.000244	0.00136	CcSEcCtD
Ergonovine—Nausea—Dexamethasone—atopic dermatitis	0.000244	0.00136	CcSEcCtD
Ergonovine—Dizziness—Prednisone—atopic dermatitis	0.000237	0.00132	CcSEcCtD
Ergonovine—Vomiting—Prednisone—atopic dermatitis	0.000228	0.00127	CcSEcCtD
Ergonovine—Headache—Prednisone—atopic dermatitis	0.000224	0.00125	CcSEcCtD
Ergonovine—Nausea—Prednisone—atopic dermatitis	0.000213	0.00119	CcSEcCtD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	3.71e-05	0.00899	CbGpPWpGaD
Ergonovine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	3.71e-05	0.00898	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	3.54e-05	0.00857	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL13—atopic dermatitis	3.48e-05	0.00843	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	3.33e-05	0.00806	CbGpPWpGaD
Ergonovine—HTR1E—G alpha (i) signalling events—CCL5—atopic dermatitis	3.33e-05	0.00805	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—CCR3—atopic dermatitis	3.31e-05	0.00802	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CCL22—atopic dermatitis	3.24e-05	0.00783	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	3.2e-05	0.00776	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—CCL27—atopic dermatitis	3.18e-05	0.00769	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CCL22—atopic dermatitis	3.17e-05	0.00768	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	3.16e-05	0.00764	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	3.07e-05	0.00744	CbGpPWpGaD
Ergonovine—HTR1E—G alpha (i) signalling events—CCR5—atopic dermatitis	3e-05	0.00726	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL5—atopic dermatitis	2.98e-05	0.00721	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—TAC1—atopic dermatitis	2.95e-05	0.00715	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—NPS—atopic dermatitis	2.95e-05	0.00715	CbGpPWpGaD
Ergonovine—HTR2C—G alpha (q) signalling events—NPS—atopic dermatitis	2.94e-05	0.00713	CbGpPWpGaD
Ergonovine—HTR2C—G alpha (q) signalling events—TAC1—atopic dermatitis	2.94e-05	0.00713	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—CXCR3—atopic dermatitis	2.89e-05	0.00701	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CCL27—atopic dermatitis	2.88e-05	0.00698	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	2.83e-05	0.00685	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CCL27—atopic dermatitis	2.83e-05	0.00684	CbGpPWpGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	2.78e-05	0.00673	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CCL22—atopic dermatitis	2.7e-05	0.00653	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	2.68e-05	0.0065	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	2.64e-05	0.0064	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	2.63e-05	0.00638	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	2.63e-05	0.00638	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CCL17—atopic dermatitis	2.59e-05	0.00626	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	2.55e-05	0.00618	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CCL17—atopic dermatitis	2.54e-05	0.00614	CbGpPWpGaD
Ergonovine—ADRA1A—G alpha (q) signalling events—TAC1—atopic dermatitis	2.5e-05	0.00606	CbGpPWpGaD
Ergonovine—ADRA1A—G alpha (q) signalling events—NPS—atopic dermatitis	2.5e-05	0.00606	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CCL27—atopic dermatitis	2.4e-05	0.00582	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.38e-05	0.00577	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—CXCL10—atopic dermatitis	2.34e-05	0.00566	CbGpPWpGaD
Ergonovine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	2.28e-05	0.00553	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	2.28e-05	0.00552	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	2.24e-05	0.00542	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	2.24e-05	0.00542	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	2.23e-05	0.0054	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	2.19e-05	0.0053	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL10—atopic dermatitis	2.18e-05	0.00527	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	2.17e-05	0.00526	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CCL17—atopic dermatitis	2.16e-05	0.00522	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL4—atopic dermatitis	2.12e-05	0.00513	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CCL11—atopic dermatitis	2.08e-05	0.00505	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	2.08e-05	0.00504	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—FCER2—atopic dermatitis	2.06e-05	0.00498	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CCL11—atopic dermatitis	2.04e-05	0.00495	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—CCL5—atopic dermatitis	2.01e-05	0.00488	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	1.95e-05	0.00472	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	1.95e-05	0.00472	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	1.91e-05	0.00463	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCL22—atopic dermatitis	1.91e-05	0.00463	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	1.9e-05	0.00459	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—CCR3—atopic dermatitis	1.87e-05	0.00453	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	1.86e-05	0.0045	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—CCR5—atopic dermatitis	1.81e-05	0.00439	CbGpPWpGaD
Ergonovine—HTR1E—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.81e-05	0.00439	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CCL11—atopic dermatitis	1.74e-05	0.00421	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCL27—atopic dermatitis	1.7e-05	0.00412	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CCR3—atopic dermatitis	1.7e-05	0.00411	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—TAC1—atopic dermatitis	1.67e-05	0.00404	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—NPS—atopic dermatitis	1.67e-05	0.00404	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CCR3—atopic dermatitis	1.67e-05	0.00403	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	1.66e-05	0.00401	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	1.66e-05	0.00401	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—CXCR3—atopic dermatitis	1.64e-05	0.00396	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CCL22—atopic dermatitis	1.63e-05	0.00394	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	1.63e-05	0.00394	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CCL27—atopic dermatitis	1.6e-05	0.00387	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—IL5—atopic dermatitis	1.55e-05	0.00375	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	1.55e-05	0.00374	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCL17—atopic dermatitis	1.53e-05	0.0037	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—TAC1—atopic dermatitis	1.51e-05	0.00367	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—NPS—atopic dermatitis	1.51e-05	0.00367	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	1.51e-05	0.00365	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CXCR3—atopic dermatitis	1.49e-05	0.0036	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—NPS—atopic dermatitis	1.48e-05	0.00359	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—TAC1—atopic dermatitis	1.48e-05	0.00359	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CXCR3—atopic dermatitis	1.46e-05	0.00353	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CCL27—atopic dermatitis	1.45e-05	0.00351	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.44e-05	0.00349	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CCR3—atopic dermatitis	1.42e-05	0.00343	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—IL5—atopic dermatitis	1.41e-05	0.00341	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	1.4e-05	0.00339	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCL22—atopic dermatitis	1.38e-05	0.00335	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—KIF3A—atopic dermatitis	1.36e-05	0.0033	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CCL27—atopic dermatitis	1.36e-05	0.00329	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	1.33e-05	0.00322	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—CXCL10—atopic dermatitis	1.32e-05	0.0032	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	1.31e-05	0.00318	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CCL17—atopic dermatitis	1.3e-05	0.00315	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	1.28e-05	0.0031	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—TAC1—atopic dermatitis	1.26e-05	0.00306	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—NPS—atopic dermatitis	1.26e-05	0.00306	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CXCR3—atopic dermatitis	1.24e-05	0.003	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCL27—atopic dermatitis	1.23e-05	0.00299	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCL11—atopic dermatitis	1.23e-05	0.00298	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CMA1—atopic dermatitis	1.23e-05	0.00298	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CXCL10—atopic dermatitis	1.2e-05	0.00291	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.2e-05	0.0029	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	1.19e-05	0.00288	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	1.19e-05	0.00288	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CXCL10—atopic dermatitis	1.18e-05	0.00285	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—STAT6—atopic dermatitis	1.16e-05	0.0028	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	1.14e-05	0.00277	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL2—atopic dermatitis	1.14e-05	0.00276	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—CCL5—atopic dermatitis	1.14e-05	0.00276	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	1.13e-05	0.00274	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	1.13e-05	0.00273	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCL17—atopic dermatitis	1.11e-05	0.00268	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—CXCL8—atopic dermatitis	1.1e-05	0.00266	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CCL11—atopic dermatitis	1.05e-05	0.00254	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FCER2—atopic dermatitis	1.03e-05	0.0025	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CCL5—atopic dermatitis	1.03e-05	0.0025	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—CCR5—atopic dermatitis	1.03e-05	0.00248	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.02e-05	0.00247	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CCL5—atopic dermatitis	1.01e-05	0.00245	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCR3—atopic dermatitis	1e-05	0.00243	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CXCL10—atopic dermatitis	1e-05	0.00242	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCL22—atopic dermatitis	9.61e-06	0.00233	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CCR3—atopic dermatitis	9.41e-06	0.00228	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CCR5—atopic dermatitis	9.31e-06	0.00225	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CCR5—atopic dermatitis	9.13e-06	0.00221	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TAC1—atopic dermatitis	8.95e-06	0.00217	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NPS—atopic dermatitis	8.95e-06	0.00217	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCL11—atopic dermatitis	8.92e-06	0.00216	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FCER2—atopic dermatitis	8.79e-06	0.00213	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CXCR3—atopic dermatitis	8.77e-06	0.00212	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CCL5—atopic dermatitis	8.61e-06	0.00209	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCL27—atopic dermatitis	8.57e-06	0.00207	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CCR3—atopic dermatitis	8.55e-06	0.00207	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—NPS—atopic dermatitis	8.39e-06	0.00203	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—TAC1—atopic dermatitis	8.39e-06	0.00203	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL5—atopic dermatitis	8.32e-06	0.00201	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—TNF—atopic dermatitis	8.29e-06	0.00201	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	8.24e-06	0.002	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CXCR3—atopic dermatitis	8.23e-06	0.00199	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCL22—atopic dermatitis	8.17e-06	0.00198	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CCR3—atopic dermatitis	8e-06	0.00194	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—IL5—atopic dermatitis	7.8e-06	0.00189	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CCR5—atopic dermatitis	7.76e-06	0.00188	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCL17—atopic dermatitis	7.69e-06	0.00186	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	7.64e-06	0.00185	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—NPS—atopic dermatitis	7.62e-06	0.00184	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—TAC1—atopic dermatitis	7.62e-06	0.00184	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CXCR3—atopic dermatitis	7.47e-06	0.00181	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	7.43e-06	0.0018	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCL27—atopic dermatitis	7.29e-06	0.00176	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCR3—atopic dermatitis	7.27e-06	0.00176	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	7.25e-06	0.00175	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—NPS—atopic dermatitis	7.13e-06	0.00173	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—TAC1—atopic dermatitis	7.13e-06	0.00173	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CXCL10—atopic dermatitis	7.09e-06	0.00172	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL5—atopic dermatitis	7.08e-06	0.00172	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CXCR3—atopic dermatitis	7e-06	0.00169	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KIF3A—atopic dermatitis	6.85e-06	0.00166	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CXCL10—atopic dermatitis	6.65e-06	0.00161	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—IL5—atopic dermatitis	6.63e-06	0.00161	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCL17—atopic dermatitis	6.53e-06	0.00158	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—TAC1—atopic dermatitis	6.48e-06	0.00157	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—NPS—atopic dermatitis	6.48e-06	0.00157	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CXCR3—atopic dermatitis	6.35e-06	0.00154	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—CXCL8—atopic dermatitis	6.2e-06	0.0015	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CMA1—atopic dermatitis	6.19e-06	0.0015	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCL11—atopic dermatitis	6.19e-06	0.0015	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.16e-06	0.00149	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCL5—atopic dermatitis	6.11e-06	0.00148	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CXCL10—atopic dermatitis	6.04e-06	0.00146	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL5—atopic dermatitis	6.02e-06	0.00146	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—IL2—atopic dermatitis	5.92e-06	0.00143	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—STAT6—atopic dermatitis	5.82e-06	0.00141	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KIF3A—atopic dermatitis	5.82e-06	0.00141	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CCL5—atopic dermatitis	5.73e-06	0.00139	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CXCL10—atopic dermatitis	5.66e-06	0.00137	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NGF—atopic dermatitis	5.65e-06	0.00137	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CXCL8—atopic dermatitis	5.63e-06	0.00136	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CXCL8—atopic dermatitis	5.52e-06	0.00134	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCR5—atopic dermatitis	5.5e-06	0.00133	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	5.5e-06	0.00133	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—IL2—atopic dermatitis	5.38e-06	0.0013	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GLB1—atopic dermatitis	5.34e-06	0.00129	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCL11—atopic dermatitis	5.27e-06	0.00128	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CMA1—atopic dermatitis	5.27e-06	0.00128	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CCL5—atopic dermatitis	5.2e-06	0.00126	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	5.17e-06	0.00125	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CCR5—atopic dermatitis	5.16e-06	0.00125	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CXCL10—atopic dermatitis	5.14e-06	0.00124	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ADSL—atopic dermatitis	5.12e-06	0.00124	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCR3—atopic dermatitis	5.05e-06	0.00122	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—STAT6—atopic dermatitis	4.95e-06	0.0012	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CCL5—atopic dermatitis	4.87e-06	0.00118	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CXCL8—atopic dermatitis	4.69e-06	0.00114	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CCR5—atopic dermatitis	4.68e-06	0.00113	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	4.67e-06	0.00113	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NFKBIA—atopic dermatitis	4.66e-06	0.00113	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NPS—atopic dermatitis	4.5e-06	0.00109	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TAC1—atopic dermatitis	4.5e-06	0.00109	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCL5—atopic dermatitis	4.42e-06	0.00107	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CXCR3—atopic dermatitis	4.41e-06	0.00107	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CCR5—atopic dermatitis	4.39e-06	0.00106	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCR3—atopic dermatitis	4.29e-06	0.00104	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL5—atopic dermatitis	4.18e-06	0.00101	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	4.09e-06	0.00099	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCR5—atopic dermatitis	3.98e-06	0.000964	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TAC1—atopic dermatitis	3.83e-06	0.000927	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NPS—atopic dermatitis	3.83e-06	0.000927	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CXCR3—atopic dermatitis	3.75e-06	0.000909	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.7e-06	0.000896	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	3.57e-06	0.000864	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	3.56e-06	0.000861	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CXCL8—atopic dermatitis	3.33e-06	0.000805	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.29e-06	0.000797	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL2—atopic dermatitis	3.18e-06	0.000769	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—IL6—atopic dermatitis	3.16e-06	0.000766	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.15e-06	0.000764	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	3.12e-06	0.000755	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	3.07e-06	0.000744	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	3.03e-06	0.000735	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	2.98e-06	0.000722	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MAPK8—atopic dermatitis	2.93e-06	0.000708	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NGF—atopic dermatitis	2.84e-06	0.000689	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	2.83e-06	0.000686	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	2.77e-06	0.00067	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	2.71e-06	0.000655	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	2.65e-06	0.000642	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	2.61e-06	0.000632	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	2.53e-06	0.000614	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	2.42e-06	0.000586	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	2.41e-06	0.000583	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	2.35e-06	0.00057	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	2.35e-06	0.000568	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	2.3e-06	0.000557	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	1.99e-06	0.000483	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL6—atopic dermatitis	1.87e-06	0.000452	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PPARA—atopic dermatitis	1.73e-06	0.00042	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	1.67e-06	0.000405	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL2—atopic dermatitis	1.6e-06	0.000387	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	1.59e-06	0.000385	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	1.47e-06	0.000356	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	1.42e-06	0.000344	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	1.36e-06	0.000329	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	1.35e-06	0.000327	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	1.25e-06	0.000303	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.07e-06	0.000259	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL6—atopic dermatitis	9.4e-07	0.000228	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	7.99e-07	0.000193	CbGpPWpGaD
